中国麻风皮肤病杂志 ›› 2019, Vol. 35 ›› Issue (7): 445-448.doi: 10.12144/zgmfskin201907445

• 综述 • 上一篇    

生物制剂治疗特应性皮炎的研究进展

王滋鸿  柏冰雪   

  1. 哈尔滨医科大学附属第二医院皮肤性病科，哈尔滨医科大学，黑龙江哈尔滨,150001
  • 出版日期:2019-07-15 发布日期:2019-07-12
  • 通讯作者: 柏冰雪，E-mail：bxuebdd@163.com

Research progress of thebiologicals for treating atopic dermatitis

WANG Zihong, BAI Bingxue   

  1. Department of Dermatovenereology, The Second Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin 150001, China
  • Online:2019-07-15 Published:2019-07-12
  • Contact: BAI Bingxue, E-mail: bxuebdd@163.com

PDF (PC)

173

摘要： 特应性皮炎（AD）是一种多发于儿童，并可累及成人的慢性炎症性皮肤病，针对参与疾病发展的特定细胞因子的靶向生物制剂对AD的治疗有效。本文对生物制剂的研究进展做一简要综述。

关键词: 特应性皮炎, 生物制剂, 单克隆抗体

Abstract: Atopic dermatitis (AD) is a chronic inflammatory skin disease that affects children and adults. Biologicals targeting specific cytokines involved in the development of the disease  play an important role in the treament of AD. The update of biologicals for the treatment of AD is reviewd.

Key words: atopic dermatitis, biologicals, monoclonal antibody